Medicines Manufacturing Data Institute: Phase 1
UK registered organisations can apply for a share of up to £500,000 for a phase 1 project to establish the Medicines Manufacturing Data Institute (MMDI). This funding is from Innovate UK.
Competition opens: Monday 7 September 2026 Competition closes: Wednesday 14 October 2026 11:00am
Start new application Or sign in to continue an existing application.
Description
Innovate UK, part of UK Research and Innovation (UKRI), will invest up to £500,000 from the UKRI Life Sciences Growth Sector.
The aim of this phase 1 competition is to provide seed funding to establish a consortium and prepare a case for an award in phase 2 to establish the Medicines Manufacturing Data Institute (MMDI).
Funding type
Grant
Project size
Your project’s grant funding request must be between £50,000 and £100,000.
Who can apply
Your project
- Grant request between £50,000 and £100,000
- Matches total project costs
- Duration 3‑6 months
- Start not before 1 January 2027
- End by 30 June 2027
- Lead organisation must be a UK registered business, academic institution, research and technology organisation, charity, not‑for‑profit or public sector body able to convene the medicines manufacturing ecosystem and enable industry to drive strategic direction.
Summary
This phase 1 competition offers seed funding to form a consortium and develop a strong phase 2 proposal for the Medicines Manufacturing Data Institute, a trusted national data hub for medicines development and manufacturing.